Pediatric Neurology
Neurology
Dr. Edward H. Kovnar, MD
|
|
Give Review
Edward Kovnar practices Neurology. He went to medical school at Washington University School of Medicine in St. Louis. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Fellow (FAAP)", "Top MD", "Best Doctors in America" and "Super Doctor". Edward Kovnar is a published physician. He published 38 publications, including: 'Current therapy and new perspectives in the treatment of medulloblastoma.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neuro...
- There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic Brainstem tumors: results of a Pediatric Oncol...
- Current therapy and new perspectives in the treatment of Medulloblastoma.
- Multiple causes of Cerebrovascular events in children with tumors of the parasellar region.
- A phase II study of every other day high-dose ifosfamide in pediatric Brain tumors: a Pediatric Oncology Group Study.
- High-activity 125I interstitial irradiation in the treatment of pediatric central Nervous system tumors: a pilot study.
- Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS Tumors.
- Quality of survival among children treated for Brain stem glioma.
- Hyperfractionated irradiation and concurrent cisplatin in Brain stem tumors: a Pediatric Oncology Group pilot study (9139).
- Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy.
- Peritoneal metastases in two patients with pineoblastoma and ventriculo-peritoneal shunts.
- Predominance of pilocytic histology in dorsally exophytic Brain stem tumors.
- Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution.
- Relation of tumor-cell ploidy to survival in children with Medulloblastoma.
- High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant Gliomas.
- A phase II evaluation of thiotepa in pediatric central Nervous system malignancies.
- Response of pediatric low grade Gliomas to chemotherapy.
- A phase I study of ifosfamide given on alternate days to treat children with Brain tumors.
- Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status.
- Neuraxis dissemination in pediatric Brain tumors. Response to preirradiation chemotherapy.
- Primary extracranial neuroblastoma with central Nervous system metastases characterization by clinicopathologic findings and neuroimaging.
- High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell Disease.
- Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central Nervous system: a phase II study.
- Variability in the disposition of intraventricular methotrexate: a proposal for rational dosing.
- Neurodevelopmental status of infants and young children treated for Brain tumors with preirradiation chemotherapy.
- A hazard of using adult-sized weighted-tip enteral feeding catheters in infants.
- Feasibility and efficacy of preirradiation chemotherapy for pediatric Brain tumors.
- Psychologic and neurologic function following treatment for childhood temporal lobe Astrocytoma.
- Brainstem auditory evoked potentials in normal term and premature infants.
- Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment.
- Limiting Toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemia.
- Potentiation of ifosfamide neuroToxicity, hematoToxicity, and tubular nephroToxicity by prior cis-diamminedichloroplatinum(II) therapy.
- Serial neuropsychological studies of a child with acute lymphoblastic leukemia and subsequent glioblastoma multiforme.
- Serial lumbar punctures for at least temporary amelioration of neonatal posthemorrhagic Hydrocephalus.
- Late effects of radiotherapy on patients with cerebellar Medulloblastoma.
- Rapidly progressive posthemorrhagic Hydrocephalus. Treatment with external ventricular drainage.
- Normal neurologic development and marked reconstitution of Cerebral mantle after postnatal treatment of intrauterine hydrocephalus.
Schools
Washington University In St Louis School Of Medicine
St Louis Children39s Hospital
Barnes Hospital
Saint Louis Children39s Hospital
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Clinical Neurophysiology
- Neurodevelopmental Disabilities
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Fellow (FAAP)
- Top MD
- Best Doctors in America
- Super Doctor
Education
-
Washington University -
Washington University School of Medicine in St. Louis
Hospital
-
Children's Hospital of Wisconsin
Drug Facts
| NPI NUMBER | 1366472524 | |
| NPPES Provider LastName | KOVNAR | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 532092042 | |
| NPPES Provider State | WI | |
| Specialty Description | Neurology | |
| Total Claim Count | 237.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366472524 |
| Last Name Of The Provider | KOVNAR |
| First Name Of The Provider | EDWARD |
| View All |